Physical therapy for a patient through six stages of amyotrophic lateral sclerosis

Physical Therapy

Volumn 78, Issue 12, 1998, Pages 1312-1324

  Dal Bello Haas, Vanina ^a   Kloos, Anne D ^a   Mitsumoto, Hiroshi ^a  

^a NONE

Author keywords

Amyotrophic lateral sclerosis; Physical therapy; Staging of disease

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CASE REPORT; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HUMAN; MUSCLE WEAKNESS; ORTHOSIS; PATIENT EDUCATION; PHYSIOTHERAPY; PSYCHOLOGICAL ASPECT; REHABILITATION; STAGING; TREATMENT OUTCOME;

EID: 0031699630     PISSN: 00319023     EISSN: None     Source Type: Journal    
DOI: 10.1093/ptj/78.12.1312     Document Type: Article

References (55)

1. Mitsumoto H, Chad DA, Pioro EK. Amyotrophic Lateral Sclerosis. Philadelphia, Pa: FA Davis Co; 1998.
2. Juergens SM, Kurland KT. Epidemiology. In: Mulder D, ed. The Diagnosis and Treatment of Amyotrophic Lateral Sclerosis. Boston, Mass: Houghton Mifflin Co; 1980:35-46.
3. Tandan R, Bradley WG. Amyotrophic lateral sclerosis, part 1: clinical features, pathology, and ethical issues in management. Ann Neurol. 1985;18:271-180.
4. Dworkin JP, Hartman DE. Progressive speech deterioration and dysphagia in amyotrophic lateral sclerosis: case report. Arch Phys Med Rehabil. 1979;60:423-425.
5. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59-62.
6. Bredesen DE, Ellerby LM, Hart PJ, et al. Do posttranslational modifications of CuZnSOD lead to sporadic amyotrophic lateral sclerosis? Ann Neurol. 1997;42:135-137.
7. Bowling AC, Schulz JB, Brown RH Jr, Beal MF. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem. 1993; 61:2322-2325.
8. Kawamata J, Shimohama S, Takano S, et al. Novel G16S (GGC-AGC) mutation in the SOD-1 gene in a patient with apparently sporadic young-onset amyotrophic lateral sclerosis. Hum Mutat. 1997;9:356-358.
9. Hirano A. Cytopathology in amyotrophic lateral sclerosis. Adv Neurol. 1991;56:91-101.
10. Collard JF, Cote F, Julien JP. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature. 1995;375:61-64.
11. Rothstein JD, Tsai GT, Kuncl RW, et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1990;28: 18-25.
12. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med. 1992;236:1464-1468.
13. Appel SH, Stockton-Appel V, Stewart SS, Kerman RH. Amyotrophic lateral sclerosis: associated clinical disorders and immunological evaluations. Arch Neurol. 1986;43:234-238.
14. Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis: ALS/Riluzole Study Group. N Engl J Med. 1994;330:585-591.
15. Lange DJ, Felice KJ, Festoff BW, et al. Recombinant human insulin-like growth factor-I in ALS: description of a double-blind, placebo-controlled study - North American ALS/IGF-I Study Group. Neurology. 1996;47(4 suppl 2):S93-S94; discussion S94-S95.
16. Sinaki M, Mulder DW. Rehabilitation techniques for patients with amyotrophic lateral sclerosis. Mayo Clin Proc. 1978;53:173-178.
17. Sinaki M. Rehabilitation. In: Mulder DW, ed. The Diagnosis and Treatment of Amyotrophic Lateral Sclerosis. Boston, Mass: Houghton Mifflin Co; 1980:171-193.
18. Bennett RL, Knowlton GC. Overwork weakness in partially denervated skeletal muscle. Clin Orthop. 1958;12:22-29.
19. Smith RA, Norris FH Jr. Symptomatic care of patients with amyotrophic lateral sclerosis. JAMA. 1975;234:715-717.
20. Wagner MB, Vignos PJ Jr, Fonow DC. Serial isokinetic evaluations used for a patient with scapuloperoneal muscular dystrophy: a case report. Phys Ther. 1986;66:1110-1113.
21. Peach PE. Overwork weakness with evidence of muscle damage in a patient with residual paralysis from polio. Arch Phys Med Rehabil. 1990;71:248-250.
22. Norris FH. Exercise for patients with neuromuscular diseases. West J Med. 1985;142:261.
23. Bohannon RW. Results of resistance exercise on a patient with amyotrophic lateral sclerosis: a case report. Phys Ther. 1983;63:965-968.
24. Sanjak M, Paulson D, Sufit R, et al. Physiologic and metabolic response to progressive and prolonged exercise in amyotrophic lateral sclerosis. Neurology. 1987;37:1217-1220.
25. Kilmer DD, McCrory MA, Wright NC, et al. The effect of a high-resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil. 1994;75:560-563.
26. Lindeman E, Leffers P, Spaans F, et al. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Arch Phys Med Rehabil. 1995;76: 612-620.
27. Aitkens SG, McCrory MA, Kilmer DD, Bernauer EM. Moderate resistance exercise program: its effect in slowly progressive neuromus-cular disease. Arch Phys Med Rehabil. 1993;74:711-715.
28. Milner-Brown HS, Miller RG. Muscle strengthening through electric stimulation combined with low-resistance weights in patients with neuromuscular disorders. Arch Phys Med Rehabil. 1988;69:20-24.
29. Wright NC, Kilmer DD, McCrory MA, et al. Aerobic walking in slowly progressive neuromuscular disease: effect of a 12-week program. Arch Phys Med Rehabil. 1996;77:64-69.
30. Florence JM, Hagberg JM. Effect of training on the exercise responses of neuromuscular disease patients. Med Sci Sports Exerc. 1984;16:460-465.
31. Frownfelter D, Dean E. Principles and Practice of Cardiopulmonary Physical Therapy. 3rd ed. St Louis, Mo: CV Mosby Co; 1996.
32. The ALS Ciliary Neurotrophic Factor Treatment Study (ACTS) Phase I-II Study Group. The amyotrophic lateral sclerosis functional rating scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol. 1996;53:141-147.
33. Schwab R, England A. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham J, Donaldson I, eds. Third Symposium on Parkinson's Disease. Edinburgh, Scotland: Churchill Livingstone; 1969:152-157.
34. Andres PL, Hedlund W, Finison L, et al. Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology. 1986;36:937-941.
35. de Boer A, Boukes RJ, Sterk JC. Reliability of dynamometry in patients with a neuromuscular disorder. N Engl J Med. 1982;11:169-174.
36. Scott OM, Hyde SA, Goddard C, Dubowitz V. Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve. 1982;5:291-301.
37. Wiles CM, Karni Y. The measurement of muscle strength in patients with peripheral neuromuscular disorders. J Neurol Neurosurg Psychiatry. 1983;46:1006-1013.
38. Wade DT. Measurement in Neurological Rehabilitation. Oxford, England: Oxford University Press; 1992.
39. Fletcher SG. Time-by-count measurement of diadochokinetic syllable rate. J Speech Hear Res. 1972;15:763-770.
40. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner. 1964;192:540-544.
41. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67:206-207.
42. Smith HD. Assessment and evaluation: an overview. In: Hopkins HL, Smith HD, eds. Willard and Spackman's Occupational Therapy. 7th ed. Philadelphia, Pa: JB Lippincott Co; 1993:227.
43. Griggs RC, Donohoe KM, Utell MJ, et al. Evaluation of pulmonary function in neuromuscular disease. Arch Neurol. 1981;38:9-12.
44. Fallat RJ, Jewitt B, Bass M, et al. Spirometry in amyotrophic lateral sclerosis. Arch Neurol. 1979;36:74-80.
45. The World Federation of Neurology Research Group on Neuromuscular Diseases, Subcommittee on Motor Neuron Disease. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1994;124(suppl):96-107.
46. Bannister R. Brain's Clinical Neurology. 6th ed. New York, NY: Oxford University Press Inc; 1985.
47. Medical Research Council. Aids to the Examination of the Peripheral Nervous System. London, England: Her Majesty's Stationary Office; 1976.
48. American Academy of Orthopaedic Surgeons. Joint Motion: Method of Measuring and Recording. 11th ed. New York, NY: Churchill Livingstone Inc; 1983.
49. Rothstein JM, Miller PJ, Roettger RF. Goniometric reliability in the clinical setting: elbow and knee measurements. Phys Ther. 1983;63: 1611-1615.
50. Wadsworth CT, Krishnan R, Sear M, et al. Intrarater reliability of manual muscle testing and hand-held dynametric muscle testing. Phys Ther. 1987;67:1342-1347.
51. Frese E, Brown M, Norton BJ. Clinical reliability of manual muscle testing: middle trapezius and gluteus medius muscles. Phys Ther. 1987;67:1072-1076.
52. Mathiowetz V, Kashman N, Volland G, et al. Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil. 1985;66:69-74.
53. Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg Am. 1984;9:222-226.
54. Bohannon RW, Larkin PA, Cook AC, et al. Decrease in timed balance test scores with aging. Phys Ther. 1984;64:1067-1070.
55. McDonald E. Psychosocial-spiritual overview. In: Mitsumoto H, Norris FH Jr, eds. Amyotrophic Lateral Sclerosis: A Comprehensive Guide to Management. New York, NY: Demos Publications; 1994:205-227.